Expression of the immunoproteasome subunit β5i in non-small cell lung carcinomas.

Takayuki KiuchiUtano TomaruAkihiro IshizuMakoto ImagawaSari IwasakiAkira SuzukiNoriyuki OtsukaYoshihito OhharaIchiro KinoshitaYoshihiro MatsunoHirotoshi Dosaka-AkitaMasanori Kasahara

Published in: Journal of clinical pathology (2020)

The expression of immunoproteasome can be explored as both a prognostic factor and a potential therapeutic target in NSCLCs. Since immunoproteasomes have crucial role in the antigen presentation, further studies may help to provide essential knowledge for therapeutic strategies in anticancer immunotherapy.

Keyphrases

prognostic factors
poor prognosis
healthcare
single cell
long non coding rna
cell therapy
high grade
risk assessment
bone marrow